10x Genomics, Inc.
TXG- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001770787
In the last 90 days, 10x Genomics, Inc. insiders filed 0 open-market purchases and 11 sales; 393 institutions reported holding it in 13F filings for Q2 2026, worth $4.92B in total; superinvestors ARK Invest and Duquesne Family Office hold it.
13F holders, Q4 2023
Institutional positions in 10x Genomics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 275
- +23 vs. Q3 2023
- Shares held
- 96.0M
- +6.55M (+7.3%) vs. Q3 2023
- Total value
- $5.37B
- +$1.67B (+45.0%) vs. Q3 2023
- New holders
- 60
- 97 more added
- Sold out
- 37
- 81 more reduced
5 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TXG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 393 | $4.92B |
| Q1 2026 | 332 | $2.66B |
| Q4 2025 | 323 | $2.01B |
| Q3 2025 | 317 | $1.44B |
| Q2 2025 | 297 | $1.42B |
| Q1 2025 | 274 | $995.9M |
| Q4 2024 | 273 | $1.50B |
| Q3 2024 | 266 | $2.36B |
| Q2 2024 | 261 | $2.05B |
| Q1 2024 | 290 | $3.89B |
| Q4 2023 | 275 | $5.37B |
| Q3 2023 | 257 | $3.75B |
| Q2 2023 | 274 | $4.98B |
| Q1 2023 | 259 | $5.03B |
| Q4 2022 | 268 | $3.19B |
| Q3 2022 | 234 | $2.45B |
| Q2 2022 | 254 | $3.91B |
| Q1 2022 | 313 | $6.30B |
| Q4 2021 | 365 | $11.9B |
| Q3 2021 | 332 | $11.5B |
| Q2 2021 | 342 | $15.3B |
| Q1 2021 | 324 | $12.8B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding 10x Genomics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Versor Investments LP | 0 | $0 | 0.00% | −6,683−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −6,186−100.0% | Sold out |
| Counterpoint Mutual Funds LLC | 0 | $0 | 0.00% | −5,177−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,754−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −583−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −523−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Grove Bank & Trust | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Authentikos Wealth Advisory, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Northwest Investment Counselors, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| AMH Equity Ltd | 0 | $0 | 0.00% | −203−100.0% | Sold out |
| Foresite Capital Management II, LLC | – | – | – | – | Not filed |
| Decheng Capital Management III (Cayman), LLC | – | – | – | – | Not filed |
| Ropes Wealth Advisors LLC | – | – | – | – | Not filed |
| Column Capital Advisors, LLC | – | – | – | – | Not filed |
| Johnson Midwest Financial, LLC | – | – | – | – | Not filed |